Roche’s Accu-Chek Connect Diabetes Management App has hit yet another snag with the FDA. On February 15, the agency issued a Class 2 Device Recall for certain software versions of the app due to a bug that could lead users to self-administer inappropriate doses of insulin.
from MobiHealthNews http://ift.tt/2oeOBiF
February 21, 2018
Rose
MobiHealthNews
No comments
Related Posts:
Telemedicine services appear to drive genetic testingResearchers at the University of Pennsylvania School of Medicine have found that telemedicine services could lead to an increase in genetic counseling in community care centers, according to an abstract that will be presented… Read More
Digital health news briefs for 5/31/2018Stamp of approval. The Center for Disease Control and Prevention has just granted the diabetes management platform Omada Health a full recognition status. Companies that get the designation must first meet the CDC’s standards… Read More
Startup Oshi Health launches disease management platform for IBD patientsOshi Health, a digital startup focused on digestive health, has launched a mobile app specifically designed to help inflammatory bowel disease patients understand and manage their condition. from MobiHealthNews https://ift.t… Read More
Text-based tool reduces patient no-shows by more than two-thirdsRiverside Medical Clinic is the largest physician-owned practice in California. It is a multi-specialty enterprise that has more than 170 providers and sees more than 400,000 patient visits a year. As such, it has a great nee… Read More
In-Depth: Four major telemedicine trends of 2018Telemedicine continues to move from the peripheries of healthcare into the mainstream. from MobiHealthNews https://ift.tt/2J9HVuE … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment